Laxmi Organic Industries Ltd
Laxmi Organic Industries Limited was established in 1989 and is in the business of specialty chemicals. The Company primarily manufactures Ethyl Acetate, Acetic Acid and Diketene Derivative Products (DDP). DDP is a specialty chemical group, the technology and business of which has been acquired by the company from Clariant Chemicals India Limited.
The company’s business operations are carried in over 30 countries including 11 offices located in India
- Market Cap ₹ 5,486 Cr.
- Current Price ₹ 198
- High / Low ₹ 326 / 160
- Stock P/E 48.3
- Book Value ₹ 68.8
- Dividend Yield 0.25 %
- ROCE 8.82 %
- ROE 6.13 %
- Face Value ₹ 2.00
Pros
Cons
- Stock is trading at 2.88 times its book value
- Company has a low return on equity of 7.40% over last 3 years.
- Dividend payout has been low at 12.2% of profits over last 3 years
- Promoter holding has decreased over last 3 years: -3.54%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|
1,074 | 1,047 | 1,076 | 1,376 | 1,569 | 1,534 | 1,768 | 3,084 | 2,791 | 2,863 | 2,985 | |
988 | 966 | 957 | 1,222 | 1,414 | 1,418 | 1,548 | 2,713 | 2,548 | 2,605 | 2,706 | |
Operating Profit | 86 | 80 | 119 | 154 | 155 | 117 | 220 | 371 | 243 | 259 | 280 |
OPM % | 8% | 8% | 11% | 11% | 10% | 8% | 12% | 12% | 9% | 9% | 9% |
1 | 2 | 2 | 3 | 6 | 30 | 4 | 15 | 18 | 28 | 25 | |
Interest | 26 | 19 | 11 | 12 | 19 | 17 | 19 | 19 | 15 | 9 | 20 |
Depreciation | 30 | 29 | 28 | 31 | 44 | 49 | 47 | 48 | 72 | 107 | 124 |
Profit before tax | 31 | 34 | 82 | 113 | 98 | 81 | 158 | 319 | 173 | 171 | 161 |
Tax % | 31% | 22% | 13% | 33% | 26% | 13% | 20% | 19% | 28% | 29% | 29% |
21 | 27 | 72 | 76 | 72 | 70 | 127 | 257 | 125 | 121 | 114 | |
EPS in Rs | 21.12 | 26.56 | 71.50 | 75.63 | 14.46 | 15.57 | 4.82 | 9.76 | 4.70 | 4.37 | 4.10 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 11% | 10% | 7% | 11% | 14% | 12% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 14% |
3 Years: | -1% |
TTM: | 4% |
Compounded Profit Growth | |
---|---|
10 Years: | 18% |
5 Years: | 18% |
3 Years: | -24% |
TTM: | -4% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -12% |
1 Year: | -24% |
Return on Equity | |
---|---|
10 Years: | 12% |
5 Years: | 11% |
3 Years: | 7% |
Last Year: | 6% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10 | 10 | 10 | 10 | 50 | 45 | 53 | 53 | 53 | 55 | 55 |
Reserves | 199 | 225 | 295 | 369 | 400 | 382 | 982 | 1,237 | 1,359 | 1,742 | 1,851 |
249 | 221 | 104 | 215 | 175 | 159 | 149 | 139 | 406 | 143 | 258 | |
152 | 176 | 240 | 300 | 389 | 484 | 654 | 820 | 595 | 887 | 880 | |
Total Liabilities | 610 | 632 | 649 | 895 | 1,014 | 1,069 | 1,838 | 2,249 | 2,412 | 2,827 | 3,045 |
226 | 215 | 202 | 293 | 346 | 338 | 325 | 379 | 715 | 879 | 1,166 | |
CWIP | 25 | 40 | 61 | 30 | 31 | 67 | 148 | 374 | 447 | 444 | 398 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 5 | 23 | 126 | 148 |
358 | 377 | 386 | 571 | 637 | 664 | 1,361 | 1,492 | 1,228 | 1,378 | 1,332 | |
Total Assets | 610 | 632 | 649 | 895 | 1,014 | 1,069 | 1,838 | 2,249 | 2,412 | 2,827 | 3,045 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|
80 | 150 | -7 | 188 | 196 | 106 | 65 | 199 | 562 | 108 | ||
-21 | -37 | -85 | -123 | -56 | -641 | 76 | -384 | -490 | -268 | ||
-57 | -107 | 85 | -63 | -123 | 527 | -124 | 232 | -42 | 90 | ||
Net Cash Flow | 1 | 6 | -7 | 2 | 16 | -7 | 17 | 47 | 30 | -70 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 64 | 67 | 79 | 86 | 76 | 86 | 90 | 79 | 75 | 74 | 66 |
Inventory Days | 37 | 57 | 37 | 55 | 57 | 51 | 63 | 64 | 58 | 54 | 71 |
Days Payable | 52 | 67 | 85 | 81 | 105 | 138 | 148 | 122 | 92 | 145 | 131 |
Cash Conversion Cycle | 49 | 56 | 30 | 60 | 28 | -1 | 5 | 21 | 41 | -16 | 6 |
Working Capital Days | 65 | 66 | 36 | 65 | 43 | 25 | 27 | 58 | 66 | 24 | 55 |
ROCE % | 12% | 22% | 25% | 19% | 12% | 20% | 26% | 12% | 9% | 9% |
Documents
Announcements
-
Intimation Of Change In The Senior Leadership Team
1d - President Manufacturing retires July 31; Rajesh Naik appointed successor from August 1, 2025.
-
Intimation Of Appointment Of Senior Management Personnel Of The Company
1d - Appointment of Dr. Keshav Ruthiya as Chief Procurement Officer effective August 1, 2025.
-
Closure of Trading Window
2d - Trading window closed from July 1 until 48 hours post Q1 June 30, 2025 results announcement.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
18 Jun - Scheduled analyst/investor meetings on June 25, 2025, in Mumbai; no UPSI to be discussed.
-
Disclosure (Details Of Litigation) As Required Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
16 Jun - Update on litigation with MSEDCL; writ dismissed, petition filed with MERC, SLP pending in Supreme Court.
Annual reports
Concalls
-
May 2025Transcript PPT
-
May 2025TranscriptNotesPPT
-
Jan 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Jul 2024TranscriptNotesPPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT
-
Oct 2023Transcript PPT REC
-
Oct 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT
-
Jul 2023TranscriptNotesPPT
-
May 2023TranscriptPPT
-
May 2023Transcript PPT
-
Jan 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
Jul 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
May 2021Transcript PPT
Product Portfolio[1]
a) Essentials Segment
The Segment includes products like Ethyl Acetate, Acetic Anhydride, Acetaldehyde, various solvents, ethanol, and n-Butyl/Ethyl Acetate. These cater primarily to the pharmaceutical, packaging, and industrial sectors.